Stock Analysis

Bayer CropScience Full Year 2025 Earnings: EPS: ₹126 (vs ₹165 in FY 2024)

NSEI:BAYERCROP
Source: Shutterstock
Advertisement

Bayer CropScience (NSE:BAYERCROP) Full Year 2025 Results

Key Financial Results

  • Revenue: ₹54.7b (up 7.2% from FY 2024).
  • Net income: ₹5.68b (down 23% from FY 2024).
  • Profit margin: 10% (down from 14% in FY 2024). The decrease in margin was driven by higher expenses.
  • EPS: ₹126 (down from ₹165 in FY 2024).
revenue-and-expenses-breakdown
NSEI:BAYERCROP Revenue and Expenses Breakdown July 26th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Bayer CropScience Earnings Insights

The primary driver behind last 12 months revenue was the India segment contributing a total revenue of ₹52.1b (95% of total revenue). Notably, cost of sales worth ₹34.1b amounted to 62% of total revenue thereby underscoring the impact on earnings.Explore how BAYERCROP's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India.

Performance of the Indian Chemicals industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 1 warning sign for Bayer CropScience that you need to be mindful of.

Valuation is complex, but we're here to simplify it.

Discover if Bayer CropScience might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:BAYERCROP

Bayer CropScience

Engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally.

Flawless balance sheet with reasonable growth potential.

Advertisement